Skip to main content
2 AZ cancer drugs granted orphan status from FDA
1/21/2020

Two cancer drugs by AstraZeneca, lung cancer treatment Imfinzi and tremelimumab, have both received the FDA's orphan drug designation. Both drugs are currently being tested as a combo therapy in patients with liver cancer in the company's late-stage study dubbed Himalaya.

Full Story: